Entry of leukocytes into tissues is a key feature of inflammation. New data suggest the polysaccharide heparan sulfate is required for several stages of this entry process.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Ris
References
Turnbull, J., Powell, A. & Guimond, S. Trends Cell Biol. 11, 75–82 (2001).
Esko, J.D. & Selleck, S.B. Annu. Rev. Biochem. 71, 435–471 (2002).
Gotte, M. FASEB J. 17, 575–591 (2003).
Middleton, J. et al. Cell 91, 385–395 (1997).
Wang, L., Fuster, M., Sriramarao, P. & Esko, J.D. Nat. Immunol. 6, 902–910 (2005).
Lowe, J.B. Immunol. Rev. 186, 19–36 (2002).
Kannagi, R. Curr. Opin. Struct. Biol. 12, 599–608 (2002).
Ley, K. Microcirculation 10, 289–295 (2003).
Rosen, S.D. Annu. Rev. Immunol. 22, 129–156 (2004).
Nelson, R.M. et al. Blood 82, 3253–3258 (1993).
Wang, L., Brown, J.R., Varki, A. & Esko, J.D. J. Clin. Invest. 110, 127–136 (2002).
Freeman, C. et al. J. Biol. Chem. 280, 8842–8849 (2005).
Acknowledgements
The author thanks the National Health and Medical Research Council of Australia for support.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Parish, C. Heparan sulfate and inflammation. Nat Immunol 6, 861–862 (2005). https://doi.org/10.1038/ni0905-861
Issue Date:
DOI: https://doi.org/10.1038/ni0905-861
